SPONSOR
Daniel Claassen
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Autonomic FailurePure Autonomic FailureParkinson DiseaseMultiple System AtrophyDementia With Lewy Bodies
Daniel Claassen is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Autonomic Failure, Pure Autonomic Failure, Parkinson Disease, Multiple System Atrophy.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Daniel Claassen
How many clinical trials has Daniel Claassen sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Daniel Claassen, of which 1 are actively recruiting participants. These trials cover conditions including Autonomic Failure, Pure Autonomic Failure, Parkinson Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Daniel Claassen research focus on?
Daniel Claassen clinical trials span Autonomic Failure, Pure Autonomic Failure, Parkinson Disease, Multiple System Atrophy, Dementia With Lewy Bodies. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Daniel Claassen clinical trial?
To participate in a Daniel Claassen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Daniel Claassen trials with current recruitment status updated daily.
Clinical Trials by Daniel Claassen
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology